• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INVIVE; IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INVIVE; IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT) Back to Search Results
Model Number V183
Device Problems Premature Discharge of Battery (1057); Pacing Problem (1439); Inappropriate or Unexpected Reset (2959)
Patient Problems Fall (1848); Syncope/Fainting (4411)
Event Date 02/08/2023
Event Type  Injury  
Event Description
It was reported that during a routine in-clinic follow-up, this cardiac resynchronization therapy pacemaker (crt-p) was found to have reverted to safety mode.The patient was pacemaker dependent.It was noted that the device showed a battery status of 10 to 11 months remaining during the previous in-clinic follow-up approximately 6 months ago.The physician scheduled the patient for a device replacement procedure on a future date and the patient left the clinic.While walking to their car, the patient experienced a syncopal episode and collapsed.The patient was taken to the hospital and placed on a cardiac monitor.Review of monitoring data showed pacing inhibition with left arm movement.It was noted that the device was implanted in the left pectoral area.The patient was taken to the cardiac catheterization laboratory where a temporary pacing wire was placed.This device was then explanted and replaced.The patient remained in the hospital for 2 days and was then discharged.No additional adverse patient effects were reported.The return of this device is expected.At this time, the product has not been returned.If the product is returned, analysis will be performed and this report would be updated at that time.
 
Event Description
It was reported that during a routine in-clinic follow-up, this cardiac resynchronization therapy pacemaker (crt-p) was found to have reverted to safety mode.The patient was pacemaker dependent.It was noted that the device showed a battery status of 10 to 11 months remaining during the previous in-clinic follow-up approximately 6 months ago.The physician scheduled the patient for a device replacement procedure on a future date and the patient left the clinic.While walking to their car, the patient experienced a syncopal episode and collapsed.The patient was taken to the hospital and placed on a cardiac monitor.Review of monitoring data showed pacing inhibition with left arm movement.It was noted that the device was implanted in the left pectoral area.The patient was taken to the cardiac catheterization laboratory where a temporary pacing wire was placed.This device was then explanted and replaced.The patient remained in the hospital for 2 days and was then discharged.No additional adverse patient effects were reported.The return of this device is expected.At this time, the product has not been returned.If the product is returned, analysis will be performed and this report would be updated at that time.The product has been received for analysis.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, this device was thoroughly inspected and analyzed.Interrogation of the device confirmed it was operating in safety mode due to system resets.It was confirmed that brady therapy remained available.The system resets occurred during a telemetry session and caused the device to enter safety mode.Engineers determined that this device was demonstrating behavior consistent with a high internal cell impedance within the battery.The high internal impedance resulted in the system resets due to temporary high-power consumption related to telemetry attempts and subsequent reversion to safety mode operation.Boston scientific has issued a field safety notice regarding ingenio extended life (el) and cardiac resynchronization therapy pacemaker (crt-p) devices that may exhibit this behavior.This particular device is included in the high impedance in ingenio extended life (el) pacemaker and crt-p advisory population.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INVIVE
Type of Device
IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key16368727
MDR Text Key309461829
Report Number2124215-2023-06394
Device Sequence Number1
Product Code LWP
Combination Product (y/n)N
Reporter Country CodeAS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Company Representative
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup
Report Date 06/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date04/02/2015
Device Model NumberV183
Device Catalogue NumberV183
Device Lot Number100259
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/08/2023
Initial Date FDA Received02/13/2023
Supplement Dates Manufacturer Received06/07/2023
Supplement Dates FDA Received06/07/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/08/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Life Threatening; Hospitalization;
Patient Age82 YR
Patient SexMale
-
-